518 related articles for article (PubMed ID: 18375617)
1. Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.
Cowen LE; Steinbach WJ
Eukaryot Cell; 2008 May; 7(5):747-64. PubMed ID: 18375617
[No Abstract] [Full Text] [Related]
2. Molecular Evolution of Antifungal Drug Resistance.
Robbins N; Caplan T; Cowen LE
Annu Rev Microbiol; 2017 Sep; 71():753-775. PubMed ID: 28886681
[TBL] [Abstract][Full Text] [Related]
3. Signalling mechanisms involved in stress response to antifungal drugs.
Víglaš J; Olejníková P
Res Microbiol; 2021; 172(1):103786. PubMed ID: 33038529
[TBL] [Abstract][Full Text] [Related]
4. Elucidating drug resistance in human fungal pathogens.
Xie JL; Polvi EJ; Shekhar-Guturja T; Cowen LE
Future Microbiol; 2014; 9(4):523-42. PubMed ID: 24810351
[TBL] [Abstract][Full Text] [Related]
5. Hsp90 orchestrates stress response signaling governing fungal drug resistance.
Cowen LE
PLoS Pathog; 2009 Aug; 5(8):e1000471. PubMed ID: 19714223
[No Abstract] [Full Text] [Related]
6. Dectin-2-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy.
Ambati S; Ellis EC; Lin J; Lin X; Lewis ZA; Meagher RB
mSphere; 2019 Oct; 4(5):. PubMed ID: 31666315
[No Abstract] [Full Text] [Related]
7. N-trisubstituted methylimidazoles as antifungal agents.
Casadio S; Donetti A; Coppi G
J Pharm Sci; 1973 May; 62(5):773-8. PubMed ID: 4574587
[No Abstract] [Full Text] [Related]
8. [Combinations of antimycotics].
Viviani MA
G Ital Chemioter; 1984; 31(1-2):1-6. PubMed ID: 6088336
[No Abstract] [Full Text] [Related]
9. Fungal echinocandin resistance.
Walker LA; Gow NA; Munro CA
Fungal Genet Biol; 2010 Feb; 47(2):117-26. PubMed ID: 19770064
[TBL] [Abstract][Full Text] [Related]
10. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009).
Pfaller MA; Castanheira M; Messer SA; Moet GJ; Jones RN
Diagn Microbiol Infect Dis; 2011 Jan; 69(1):45-50. PubMed ID: 21146713
[TBL] [Abstract][Full Text] [Related]
11. The influence of antifungal antibiotics on some determinants of virulence in Candida albicans and Cryptococcus neoformans cells.
Borowski J; Jakoniuk P; Jablońska W; Jakubicz W; Szpak A
Experientia; 1974 Oct; 30(10):1210-1. PubMed ID: 4611784
[No Abstract] [Full Text] [Related]
12. Antimicrobial Octapeptin C4 Analogues Active against Cryptococcus Species.
Chitty JL; Butler MS; Suboh A; Edwards DJ; Cooper MA; Fraser JA; Robertson AAB
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158283
[TBL] [Abstract][Full Text] [Related]
13. C-Type Lectin Receptor CD23 Is Required for Host Defense against
Guo Y; Chang Q; Cheng L; Xiong S; Jia X; Lin X; Zhao X
J Immunol; 2018 Oct; 201(8):2427-2440. PubMed ID: 30185519
[TBL] [Abstract][Full Text] [Related]
14. In vitro antifungal and antibiofilm activities of halogenated quinoline analogues against Candida albicans and Cryptococcus neoformans.
Zuo R; Garrison AT; Basak A; Zhang P; Huigens RW; Ding Y
Int J Antimicrob Agents; 2016 Aug; 48(2):208-11. PubMed ID: 27256584
[TBL] [Abstract][Full Text] [Related]
15. A dual-targeting antifungal is effective against multidrug-resistant human fungal pathogens.
Zhou M; Liu L; Cong Z; Jiang W; Xiao X; Xie J; Luo Z; Chen S; Wu Y; Xue X; Shao N; Liu R
Nat Microbiol; 2024 May; 9(5):1325-1339. PubMed ID: 38589468
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel antifungal agents (2).
Tsukuda T; Watanabe M; Ontsuka H; Hattori K; Shirai M; Shimma N
Bioorg Med Chem Lett; 1998 Jul; 8(14):1825-8. PubMed ID: 9873441
[TBL] [Abstract][Full Text] [Related]
17. Antifungal activity of diethyldithiocarbamate.
Allerberger F; Reisinger EC; Söldner B; Dierich MP
Mycoses; 1989 Oct; 32(10):527-30. PubMed ID: 2555712
[TBL] [Abstract][Full Text] [Related]
18. Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).
Pfaller MA; Messer SA; Jones RN; Castanheira M
J Antibiot (Tokyo); 2015 Sep; 68(9):556-61. PubMed ID: 25899126
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.
Mitsuyama J; Nomura N; Hashimoto K; Yamada E; Nishikawa H; Kaeriyama M; Kimura A; Todo Y; Narita H
Antimicrob Agents Chemother; 2008 Apr; 52(4):1318-24. PubMed ID: 18227186
[TBL] [Abstract][Full Text] [Related]
20. [Antimycotic effect of Astrantia-, Eryngium- and Sanicula saponins].
Hiller K; Friedrich E
Pharmazie; 1974 Dec; 29(12):787-8. PubMed ID: 4617889
[No Abstract] [Full Text] [Related]
[Next] [New Search]
